Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: Acromegaly remains under-recognized and under-diagnosed

Clinical Endocrinology

Volumn 72, Issue 2, 2010, Pages 203-208

  Reid, Tirissa J ^a   Post, Kalmon D ^b   Bruce, Jeffrey N ^a   Nabi Kanibir, M ^a   Reyes Vidal, Carlos M ^a   Freda, Pamela U ^a  

^a Columbia University ^*  (United States)

^b Mt Sinai Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR VOLUME;

ACROMEGALY; ADULT; AGED; COHORT STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 74549215580     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03626.x     Document Type: Article

References (30)

1. Melmed, S. (2006) Medical progress: acromegaly. New England Journal of Medicine, 355, 2558 2573.
2. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171 184.
3. Beauregard, C., Truong, U., Hardy, J. et al. (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology, 58, 86 91.
4. Mestron, A., Webb, S.M., Astorga, R. et al. (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology, 151, 439 446.
5. Swearingen, B., Barker, F.G. II., Katznelson, L. et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419 3426.
6. Ezzat, S., Strom, C. Melmed, S. (1991) Colon polyps in acromegaly. Annals of Internal Medicine, 114, 754 755.
7. Ron, E., Gridley, G., Hrubec, Z. et al. (1991) Acromegaly and gastrointestinal cancer. Cancer, 68, 1673 1677.
8. Colao, A., Vitale, G., Pivonello, R. et al. (2004) The heart: an end-organ of GH action. European Journal of Endocrinology, 151 (Suppl. 1 S93 S101.
9. Webb, S.M., Badia, X. Surinach, N.L. (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. European Journal of Endocrinology, 155, 269 277.
10. Alexander, L., Appleton, D., Hall, R. et al. (1980) Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology, 12, 71 79.
11. Bengtsson, B.A., Eden, S., Ernest, I. et al. (1988) Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica, 223, 327 335.
12. Dekkers, O.M., Biermasz, N.R., Pereira, A.M. et al. (2008) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism, 93, 61 67.
13. Pearce, J.M. (2002) Pituitary tumours and acromegaly (Pierre Marie's disease). Journal of Neurology, Neurosurgery, and Psychiatry, 73, 394.
14. Nabarro, J.D. (1987) Acromegaly. Clinical Endocrinology, 26, 481 512.
15. Molitch, M.E. (1992) Clinical manifestations of acromegaly. Endocrinology and Metabolism Clinics of North America, 21, 597 614.
16. Bates, A.S., Van't Hoff, W., Jones, J.M. et al. (1993) An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine, 86, 293 299.
17. Kauppinen-Makelin, R., Sane, T., Reunanen, A. et al. (2005) A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 4081 4086.
18. Freda, P.U., Post, K.D., Powell, J.S. et al. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3808 3816.
19. Freda, P.U., Reyes, C.M., Nuruzzaman, A.T. et al. (2003) Basal and glucose-suppressed GH levels less than 1 microg/l in newly diagnosed acromegaly. Pituitary, 6, 175 180.
20. Frantz, A.G. Rabkin, M.T. (1964) Human growth hormone. Clinical measurement, response to hypoglycemia and suppression by corticosteroids. New England Journal of Medicine, 271, 1375 1381.
21. Nachtigall, L., Delgado, A., Swearingen, B. et al. (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. Journal of Clinical Endocrinology and Metabolism, 93, 2035 2041.
22. Holdaway, I.M. Rajasoorya, C. (1999) Epidemiology of acromegaly. Pituitary, 2, 29 41.
23. Pekkarinen, T., Partinen, M., Pelkonen, R. et al. (1987) Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clinical Endocrinology, 27, 649 654.
24. Freda, P.U., Wardlaw, S.L. Post, K.D. (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. Journal of Neurosurgery, 89, 353 358.
25. Kreutzer, J., Vance, M.L., Lopes, M.B. et al. (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. Journal of Clinical Endocrinology and Metabolism, 86, 4072 4077.
26. Bevan, J.S., Atkin, S.L., Atkinson, A.B. et al. (2002) Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. Journal of Clinical Endocrinology and Metabolism, 87, 4554 4563.
27. Arita, K., Kurisu, K., Tominaga, A. et al. (2003) Mortality in 154 surgically treated patients with acromegaly: a 10-year follow-up survey. Endocrine Journal, 50, 163 172.
28. Fukuda, I., Hizuka, N., Murakami, Y. et al. (2001) Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Internal Medicine, 40, 987 992.
29. Ezzat, S., Forster, M.J., Berchtold, P. et al. (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine, 73, 233 240.
30. Klijn, J.G., Lamberts, S.W., de Jong, F.H. et al. (1980) Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. Acta Endocrinologica, 95, 289 297.